Hyponatremia in the Emergency Department: Could Biomarkers Help in Diagnosis and Treatment?

Karin  Olsson; Sofia  Enhörning; Bertil  Öhlin; Olle  Melander

doi:10.4236/ojem.2016.41003

Karin Olsson¹^*, Sofia Enhörning², Bertil Öhlin², Olle Melander²

Abstract: Objective: Hyponatremia is the most common electrolyte imbalance. The initial treatment decision is based on clinical evaluation of patient volume status but an accurate assessment is difficult, particularly differentiating mild hypovolemia from euvolemia. The aim of this study is to examine if biomarkers are valuable in the early determination of volume status and SIADH diagnosis. Methods: Blood samples were collected from an unselected patient population at entry to the Emergency Department. If the plasma sodium level (P-Na) was ≤125 mmol/L, the sample was frozen for further analysis. Mid-regional pro-atrial natriuretic peptide (MR-proANP), proadrenomedullin (MR-proADM), C-terminal prepro-vasopressin (copeptin), pro-endothelin-1 (proET-1) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were analysed. A comprehensive assessment of volume status and underlying causes was made after discharge blinded for biomarker results. Results: A total of 81 patients were included. A well substa ntiated volemic state (hypo/eu/hypervolemia) was established in 72 patients (mean age 76 years, 65% women, median P-Na 119 mmol/L). A significant association was observed between MR-proANP levels and volemic state (p = 0.0001). Data was specifically analysed with respect to distinguishing hypo- from euvolemia (n = 59) using logistic regression. In a crude analysis, MR-proANP was significantly related to euvolemia (OR: 2.54 per SD of MR-proANP, 95% CI 1.32 - 4.86, p = 0.005) and remained so after the multivariate backward elimination model (OR: 2.45 per SD of MRproANP, 95% CI 1.22 - 4.91, p = 0.012.), whereas the other studied biomarkers were not. Copeptin levels were not associated with a diagnosis of SIADH. Conclusions: MR-proANP may be of value in early determination of volume status in hyponatremic patients.

Keywords: Hyponatremia, SIADH, ANP, Copeptin

Cite this paper: Olsson, K. , Enhörning, S. , Öhlin, B. and Melander, O. (2016) Hyponatremia in the Emergency Department: Could Biomarkers Help in Diagnosis and Treatment?. Open Journal of Emergency Medicine, 4, 11-22. doi: 10.4236/ojem.2016.41003.

References

[1] Olsson, K., ?hlin, B. and Melander, O. (2013) Epidemiology and Characteristics of Hyponatremia in the Emergency Department. European Journal of Internal Medicine, 24, 110-116.
http://dx.doi.org/10.1016/j.ejim.2012.10.014

[2] Upadhyay, A., Jaber, B.L. and Madias, N.E. (2006) Incidence and Prevalence of Hyponatremia. American Journal of Medicine, 119, 30-35. http://dx.doi.org/10.1016/j.amjmed.2006.05.005

[3] Chung, H.M., Kluge, R., Schrier, R.W. and Anderson, R.J. (1987) Clinical Assessment of Extracellular Fluid Volume in Hyponatremia. American Journal of Medicine, 83, 905-908.
http://dx.doi.org/10.1016/0002-9343(87)90649-8

[4] Musch, W., Thimpont, J., Vandervelde, D., Verhaeverbeke, I., Berghmans, T. and Decaux, G. (1995) Combined Fractional Excretion of Sodium and Urea Better Predicts Response to Saline in Hyponatremia than Do Clinical and Biochemical Parameters. American Journal of Medicine, 99, 348-355. http://dx.doi.org/10.1016/S0002-9343(99)80180-6

[5] Hillier, T.A., Abbott, R.D. and Barrett, E.J. (1999) Hyponatremia: Evaluating the Correction Factor for Hyperglycemia. American Journal of Medicine, 4, 399-403.
http://dx.doi.org/10.1016/S0002-9343(99)00055-8

[6] Morgenthaler, N.G., Struck, J., Alonso, C. and Bergmann, A. (2006) Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin. Clinical Chemistry, 52, 112-119. http://dx.doi.org/10.1373/clinchem.2005.060038

[7] Fenske, W., Stork, S., Blechschmidt, A., Maier, S.G., Morgenthaler, N.G. and Allolio, B. (2009) Copeptin in the Dif- ferential Diagnosis of Hyponatremia. Journal of Clinical Endocrinology and Metabolism, 94, 123-129. http://dx.doi.org/10.1210/jc.2008-1426

[8] Caruhel, P., Mazier, C., Kunde, J., Morgenthaler, N.G. and Darbouret, B. (2009) Homogeneous Time-Resolved Fluoroimmunoassay for the Measurement of Midregional Proadrenomedullin in Plasma on the Fully Automated System B.R.A.H.M.S KRYPTOR?. Clinical Biochemistry, 42, 725-728. http://dx.doi.org/10.1016/j.clinbiochem.2009.01.002

[9] Morgenthaler, N.G., Struck, J., Thomas, B. and Bergmann, A. (2004) Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human Plasma. Clinical Chemistry, 50, 234-236. http://dx.doi.org/10.1373/clinchem.2003.021204

[10] Di Serio, F., Ruggieri, V., Varraso, L., De Sario, R., Mastrorilli, A. and Pansini, N. (2005) Analytical Evaluation of the Dade Behring Dimension RxL Automated N-Terminal proBNP (NT-proBNP) Method and Comparison with the Roche Elecsys 2010. Clinical Chemistry and Laboratory Medicine, 43, 1263-1273. http://dx.doi.org/10.1515/CCLM.2005.217

[11] Morgenthaler, N.G., Struck, J., Alonso, C. and Bergmann, A. (2005) Measurement of Midregional Proadrenomedullin in Plasma with an Immunoluminometric Assay. Clinical Chemistry, 51, 1823-1829. http://dx.doi.org/10.1373/clinchem.2005.051110

[12] Papassotiriou, J., Morgenthaler, N.G., Struck, J., Alonso, C. and Bergmann, A. (2006) Immunoluminometric Assay for Measurement of the C-Terminal Endothelin-1 Precursor Fragment in Human Plasma. Clinical Chemistry, 52, 1144-1151. http://dx.doi.org/10.1373/clinchem.2005.065581

[13] Januzzi, J., Kimmenade, R., Lainchbury, J., Bayes-Genis, A., Ordonez-Lianos, J. and Santalo-Bel, M. (2006) NT- proBNP Testing for Diagnosis and Short-Term Prognosis in Acute Destabilized Heart Failure: An International Pooled Analysis of 1256 Patients. European Heart Journal, 27, 330-337. http://dx.doi.org/10.1093/eurheartj/ehi631

[14] Saeed, B.O., Beaumont, D., Handley, G.H. and Weaver, J.U. (2002) Severe Hyponatremia: Investigation and Management in a District General Hospital. Journal of Clinical Pathology, 55, 893-896. http://dx.doi.org/10.1136/jcp.55.12.893

[15] Huda, M.S., Boyd, A., Skagen, K., Wile, D., van Heyningen, C., Watson, I., Wong, S. and Gill, G. (2006) Investigation and Management of Severe Hyponatremia in a Hospital Setting. Postgraduate Medical Journal, 82, 216-219. http://dx.doi.org/10.1136/pmj.2005.036947

[16] Clayton, J.A., Le Jeune, I.R. and Hall, I.P. (2006) Severe Hyponatremia in Medical In-Patients: Aetiology, Assessment and Outcome. Quarterly Journal of Medicine, 99, 505-511. http://dx.doi.org/10.1093/qjmed/hcl071

[17] Shapiro, D.S., Sonnenblick, M., Galperin, I., Melkonyan, L. and Munter, G. (2010) Severe Hyponatraemia in Elderly Hospitalized Patients: Prevalence, Aetiology and Outcome. Internal Medicine Journal, 40, 574-580. http://dx.doi.org/10.1111/j.1445-5994.2010.02217.x

[18] Potocki, M., Breidthardt, T., Reichlin, T., Hartwiger, S., Morgenthaler, N.G., Bergmann, A., Noveanu, M., Freidank, H., Taegtmeyer, A.B., Wetzel, K., Boldanova, T., Stelzig, C., Bingisser, R., Christ, M. and Mueller, C. (2010) Comparison of Midregional Pro-Atrial Natriuretic Peptide with N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Failure. Journal of Internal Medicine, 267, 119-129. http://dx.doi.org/10.1111/j.1365-2796.2009.02135.x

[19] Coenraad, M.J., Bolk, J.H., Fr?lich, M. and Meinders, A.E. (2007) Plasma Arginine Vasopressin and Atrial Natriuretic Peptide Concentration in Patients with Hyponatremia at Diagnosis and Following Treatment. European Journal of Internal Medicine, 18, 221-229.
http://dx.doi.org/10.1016/j.ejim.2006.11.008

[20] Roessler, A., Goswami, N., Haditsch, B., Loeppky, J.A., Lufts, F.C. and Hinghofer-Szalkay, H. (2011) Volume Regulating Hormone Responses to Repeated Head-Up Tilt and Lower Body Negative Pressure. European Journal of Clinical Investigation, 41, 863-869. http://dx.doi.org/10.1111/j.1365-2362.2011.02476.x

[21] Freitas, J., Santos, R., Azevedo, E., Carvalho, M. and Rocha-Goncalces, F. (2005) Neurohormonal Behaviour during Prolonged Orthostatic Stress in Normotensive Subjects. Revista Portuguesa de Cardiologia, 24, 81-86.

[22] Balanescu, S., Kopp, P., Gaskill, M.B., Morgenthaler, N.G., Schindler, C. and Rutishauser, J. (2011) Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-, Iso- and Hyperosmolar States. Journal of Clinical Endocrinology and Metabolism, 96, 1046-1052.
http://dx.doi.org/10.1210/jc.2010-2499

[23] Darzy, K., Dixit, K.C., Shalet, S.M., Morgenthaler, N.G. and Brabant, G. (2010) Circadian Secretion Pattern of Copeptin, the C-Terminal Vasopressin Precursor Fragment. Clinical Chemistry, 56, 1190-1191. http://dx.doi.org/10.1373/clinchem.2009.141689

[24] Maeder, M.T., Staub, D., Brutsche, M.H., Arenja, N., Socrates, T., Reiter, M., Meissner, J., Morgenthaler, N.G., Bergmann, A., Struck, J. and Mueller, C. (2010) Copeptin Response to Clinical Maximal Exercise Tests. Clinical Chemistry, 56, 674-676.
http://dx.doi.org/10.1373/clinchem.2009.136309

[25] Khan, S.Q., Dhillon, O.S., O’Brien, R.J., Struck, J., Quinn, P.A., Morgenthaler, N.G., Squire, I.B., Davies, J.E., Bergmann, A. and Ng, L. (2007) C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction. Circulation, 115, 2103-2110.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.685503

[26] Bhandari, S., Loke, I., Davies, J., Squire, I.B., Struck, J. and Ng, L. (2009) Gender and Renal Function Influence Plasma Levels of Copeptin in Healthy Individuals. Clinical Science, 116, 257-263. http://dx.doi.org/10.1042/CS20080140

[27] Struck, J., Morgenthaler, N.G. and Bergmann, A. (2005) Copeptin, a Stable Peptide Derived from the Vasopressin Precursor, Is Elevated in Serum of Sepsis Patients. Peptides, 26, 2500-2504. http://dx.doi.org/10.1016/j.peptides.2005.04.019

[28] Bartter, F.C. and Schwartz, W.B. (1967) The Syndrome of Inappropriate Secretion of Antidiuretic Hormone. American Journal of Medicine, 42, 790-806.
http://dx.doi.org/10.1016/0002-9343(67)90096-4

[29] Nigro, N., Morgenthaler, N.G., Fluri, F., Schuetz, P., Neidert, S., Stolz, D., Bingisser, R., Tamm, M., Christ-Crain, M. and Katan, M. (2011) The Use of Copeptin, the Stable Peptide of the Vasopressin Precursor, in the Differential Diagnosis of Sodium Imbalance in Patients with Acute Diseases. Swiss Medical Weekly, 141, w13270. http://dx.doi.org/10.4414/smw.2011.13270

[30] Gill, G., Huda, B., Boyd, A., Skagen, K., Wile, D., Watson, I. and van Heyningen, C. (2006) Characteristics and Mortality of Severe Hyponatremia—A Hospital Based Study. Clinical Endocrinology, 65, 246-249. http://dx.doi.org/10.1111/j.1365-2265.2006.02583.x

[31] Liamis, G., Milionis, H., Rizos, E., Siamopoulos, K. and Elisaf, M. (2000) Mechanism of Hyponatremia in Alcohol Patients. Alcohol & Alcoholism, 35, 612-616. http://dx.doi.org/10.1093/alcalc/35.6.612